It is taken up via the dopamine transporter and kills dopaminergic neurons through oxidative damage and inhibition of mitochondrial respiratory chain complexes, resulting in a decrease in dopaminergic neurons, and motor and non‐motor disorders that resemble PD (Bove & Perier, 2012; Gerlach et al., 1991). This evidence concerns the gene SLC6A3 and Parkinson disease.